Aspiring to Excellence is a strategic partnership between NASS, BRITSpA and sponsoring companies AbbVie, Biogen, Lilly, Novartis and UCB. It is an award programme designed to encourage and recognise service improvement in axial SpA (AS) care.
Aspiring to Excellence is the only programme of its kind in axial SpA and is designed to encourage and recognise service improvement in the care of patients with the condition. It provides expert support to selected rheumatology teams to help them catalyse improvements within their departments. Meet the teams taking part in the programme – The first six teams started their journey towards the end of 2019 and the second round of participants joined the programme during May 2021.
Aspiring to Excellence is a strategic partnership between NASS, BRITSpA and sponsoring companies AbbVie, Biogen, Lilly, Novartis and UCB. It is an essential component of our Every Patient, Every Time campaign.
